HomeHealthDiabetes drug Ozempic faces shortage after celebrity endorsement

Diabetes drug Ozempic faces shortage after celebrity endorsement


Ozempic, a diabetes drug that can help people lose weight, is facing shortages due to global demand and supply constraints.

The company said that while the product continues to be manufactured and shipped, patients in some areas of the country will experience delays with certain doses and instructed anyone concerned about continued treatment to contact their health care provider.

Danish drugmaker Novo Nordisk said the 1mg and 2mg doses of Ozempic are currently available to patients across the country. However, there are supply interruptions that affect the Ozempic pen that delivers 0.25 mg and 0.5 mg doses.

“While we recognize that some healthcare providers may prescribe Ozempic for patients whose goal is weight loss, it is up to each healthcare provider’s clinical judgment to choose the best treatment approach for their patients,” Novo Nordisk told Fox News Digital on a declaration. “Novo Nordisk does not promote, suggest, or encourage the off-label use of our medications and is committed to fully complying with all applicable U.S. laws and regulations in promoting our products. We trust that healthcare providers are evaluating the individual needs of a patient and determine which drug is right for that particular patient.

OZEMPIC WARNING: PHYSICIANS URGE CAUTION FOR THOSE USING DIABETES MEDICATIONS FOR WEIGHT LOSS

In November, the Australian government warned that the company informed its Therapeutic Goods Administration (TGA) that Ozempic would not be available in the country from mid-November 2022 until the end of March 2023.

The logo of the Danish pharmaceutical company Novo Nordisk is displayed at its headquarters in Bagsvaerd, on the outskirts of Copenhagen, Denmark, on February 1, 2017, the day before it publishes its annual financial results.
((Photo by LISELOTTE SABROE/Scanpix Denmark/AFP via Getty Images))

“The TGA is working with Novo Nordisk and relevant healthcare professional organizations to manage this severe shortage,” he said.

US regulators approved the drug in December 2017, which also lowers blood sugar levels.

The once a week injection is for people with type 2 diabetes and Ozempic, also known as semaglutide, works by stimulating the body’s own production of insulin and reducing appetite. It is not a weight loss medication.

Four years later, the Food and Drug Administration approved Wegovy, a higher-dose version of semaglutide, for long-term weight management.

A man prepares an Ozempic injection.

A man prepares an Ozempic injection.
(iStock)

DIABETES DRUG OZEMPIC IS TRENDY AS A WEIGHT LOSS METHOD: HERE’S WHY AND WHAT DOCTORS SAY

In recent weeks, the drug has drawn attention as celebrities and TikTok influencers have described taking it to lose weight quickly.

“Everyone suddenly shows up 25 pounds less. What happens when they stop taking #Ozempic?????” Bravo host Andy Cohen tweeted in September.

On TikTok, the #Ozempic hashtag has been viewed more than 313 million times.

Twitter boss Elon Musk tweeted that he had been taking Wegovy for weight loss in October and November.

Elon Musk attends the 2022 Met Gala Celebration "In America: A Fashion Anthology" at the Metropolitan Museum of Art on May 2, 2022 in New York City.

Elon Musk attends the 2022 Met Gala Celebrating “In America: An Anthology of Fashion” at The Metropolitan Museum of Art on May 2, 2022 in New York City.
(Photo by Dimitrios Kambouris/Getty Images for The Met Museum/Vogue))

However, doctors caution against using Ozempic, warning that the benefits may be short-lived.

Some side effects besides weight loss include vision changes, possible thyroid tumors, pancreatitis, kidney problems, and gallbladder problems.

CLICK HERE TO GET THE FOX NEWS APP

“There are side effects to this drug, but there are side effects to any drug,” Fox News medical contributor Dr. Marc Siegel said in October, “so I feel comfortable prescribing it, but I don’t think anyone can take any drug “. .”

Elizabeth Pritchett, Angelica Stabile and The Associated Press of Fox News contributed to this report.



Source link

RELATED ARTICLES
- Advertisment -

Most Popular